Imunon Statistics

Total Valuation

Imunon has a market cap or net worth of $15.30 million. The enterprise value is $10.63 million.

Market Cap	15.30M
Enterprise Value	10.63M

Important Dates

The next estimated earnings date is Monday, May 12, 2025, before market open.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Imunon has 14.50 million shares outstanding. The number of shares has increased by 27.23% in one year.

Current Share Class	14.50M
Shares Outstanding	14.50M
Shares Change (YoY)	+27.23%
Shares Change (QoQ)	+0.54%
Owned by Insiders (%)	1.54%
Owned by Institutions (%)	2.93%
Float	12.27M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.59
P/TBV Ratio	3.62
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.67, with a Debt / Equity ratio of 0.27.

Current Ratio	1.67
Quick Ratio	1.23
Debt / Equity	0.27
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -211.21% and return on invested capital (ROIC) is -117.26%.

Return on Equity (ROE)	-211.21%
Return on Assets (ROA)	-75.60%
Return on Invested Capital (ROIC)	-117.26%
Return on Capital Employed (ROCE)	-387.99%
Revenue Per Employee	n/a
Profits Per Employee	-$744,810
Employee Count	25
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -35.67% in the last 52 weeks. The beta is 1.96, so Imunon's price volatility has been higher than the market average.

Beta (5Y)	1.96
52-Week Price Change	-35.67%
50-Day Moving Average	0.92
200-Day Moving Average	1.01
Relative Strength Index (RSI)	59.99
Average Volume (20 Days)	120,214

Short Selling Information

The latest short interest is 997,876, so 6.88% of the outstanding shares have been sold short.

Short Interest	997,876
Short Previous Month	1.05M
Short % of Shares Out	6.88%
Short % of Float	8.14%
Short Ratio (days to cover)	6.68

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-19.13M
Pretax Income	-20.13M
Net Income	-18.62M
EBITDA	-18.89M
EBIT	-19.13M
Earnings Per Share (EPS)	-$1.62

Full Income Statement

Balance Sheet

The company has $5.87 million in cash and $1.14 million in debt, giving a net cash position of $4.73 million or $0.33 per share.

Cash & Cash Equivalents	5.87M
Total Debt	1.14M
Net Cash	4.73M
Net Cash Per Share	$0.33
Equity (Book Value)	4.24M
Book Value Per Share	0.29
Working Capital	3.22M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$18.85 million and capital expenditures -$29,541, giving a free cash flow of -$18.88 million.

Operating Cash Flow	-18.85M
Capital Expenditures	-29,541
Free Cash Flow	-18.88M
FCF Per Share	-$1.30

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Imunon does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-27.23%
Shareholder Yield	-27.23%
Earnings Yield	-121.20%
FCF Yield	-122.92%

Analyst Forecast

The average price target for Imunon is $21.50, which is 1,937.92% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$21.50
Price Target Difference	1,937.92%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on March 1, 2022. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Mar 1, 2022
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a